KYMR · Kymera Therapeutics, Inc.
$113.37
+2.31 (+2.08%)
At close · Jul 21
Market Cap
$9.33B
Shares
82.26M
Stock transactions by members of the U.S. Congress, disclosed under the STOCK Act. Lawmakers must report trades within 45 days, so the filing date can lag the trade itself.
No Congressional Trades
No congressional trading data is available for this stock yet.
Key facts
CIK
1815442
CUSIP
501575104
13F (30d)
21 filings
20 filers
Visit website
Investor relations